Cerapedics touts IDE bone graft trial results

This study demonstrates that treatment with i-Factor bone graft resulted in similar and on some metrics superior outcomes compared to local autograft bone,” study co-investigator Dr. Paul Arnold of the University of Kansas Medical Center said in a press release. In November, Cerapedics said it won FDA premarket approval for its I-Factor peptide enhanced bone graft for use in anterior cervical discectomy and fusion procedures for patients with degenerative cervical disc disease. Westminster, Colo.-based Cerapedics said the I-Factor graft is the 1st bone graft approved for use in cervical spine procedures and the 2nd PMA cleared bone graft for the spine. The post Cerapedics touts IDE bone graft trial results appeared first on MassDevice.
Source: Mass Device - Category: Medical Equipment Authors: Tags: Clinical Trials Spinal Cerapedics Inc. Source Type: news